摘要
探讨肠激宁治疗肠易激综合征(IBS)的疗效。60例符合罗马Ⅱ诊断标准的肠易激综合征患者,随机分为两组。治疗组30例,口服肠激宁,对照组30例,口服匹维溴铵,疗程为4周。结果:两组临床症状均能明显改善,治疗组总有效率为93. 33%,对照组为86. 67%;两组治疗后各症状积分和总积分均明显低于治疗前(P<0. 01),且治疗组优于对照组。结论:肠激宁是治疗IBS临床疗效肯定的药物。
To investigate the clinical effects of “Chang Ji Ning” in the treatment of irritable bowel syndrome(IBS), 60 subjects were randomized into two groups: treatment group in which 30 cases were treated with “Chang Ji Ning” and control group in which another 30 cases were treated with Pinaverium Bromide, with a course of 4 weeks. Results: The clinical symptoms in both groups improved, with the total effective rate of 93.33% in treatment group and 86.67% in control group; after treatment, the symptom scores and total scores reduced ( P <0 01), with better effects in treatment group than in control group. It is indicated that “Chang Ji Ning” has positive effects on irritable bowel syndrome.
出处
《上海中医药杂志》
北大核心
2005年第6期28-29,共2页
Shanghai Journal of Traditional Chinese Medicine
关键词
肠易激综合征
肠激宁
中医药疗法
Irritable bowel syndrome
“Chang Ji Ning”
Chinese medicine
